APA (7th ed.) Citation

P, M., AM, B., H, F., M, S., AD, G., HC, S., . . . SM, K. (2025). Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression. The American journal of drug and alcohol abuse, 51(5), 649. https://doi.org/10.1080/00952990.2025.2541212

Chicago Style (17th ed.) Citation

P, Manza, et al. "Ketamine to Enhance Methadone Treatment Retention in Patients with Opioid Use Disorder and Co-morbid Depression." The American Journal of Drug and Alcohol Abuse 51, no. 5 (2025): 649. https://doi.org/10.1080/00952990.2025.2541212.

MLA (9th ed.) Citation

P, Manza, et al. "Ketamine to Enhance Methadone Treatment Retention in Patients with Opioid Use Disorder and Co-morbid Depression." The American Journal of Drug and Alcohol Abuse, vol. 51, no. 5, 2025, p. 649, https://doi.org/10.1080/00952990.2025.2541212.